Landscapes / Targets
CD80
2 drugs act on CD80, in 4 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs2
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Receptor molecules, native or modified |
Bristol Myers Squibb · Public BMY |
Approved | — | ||
| How it works | A decoy protein that soaks up a signal molecule before it can reach the body's cells | ||||
| Also tested for | Rheumatoid Arthritis | ||||
| Open drug page | |||||
— |
Phase 2 | 31 Mar 2029Phase 1/2 trial completes | |||
| Next date | 31 Mar 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Metastatic Solid Tumor and 10 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 2 of 2 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026